Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer
- 1 September 2018
- journal article
- conference paper
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 106 (3) , 864-871
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapyDiseases of the Esophagus, 2013
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- The Immunological Impact of Neoadjuvant Chemotherapy on the Tumor Microenvironment of Esophageal Squamous Cell CarcinomaAnnals of Surgical Oncology, 2011
- Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancerBMC Cancer, 2011
- Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancerRadiation Oncology, 2010
- Effects of Chemoradiation on Tumor-Host Interactions: The Immunologic SideJournal of Clinical Oncology, 2008
- Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102Journal of Clinical Oncology, 2007
- Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved SurvivalJournal of Clinical Oncology, 2005
- Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the EsophagusJournal of Clinical Oncology, 2005
- The Immunobiology of Cancer Immunosurveillance and ImmunoeditingImmunity, 2004